VAR2 PHARMACEUTICALS ApS: Financial statements 2021
CVR: 34621942
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
VAR2 PHARMACEUTICALS ApS (CVR 34621942) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -4,433,183 and a net result of DKK -5,904,971 compared with DKK -5,390,471 the year before. Equity in the 2021 report amounted to DKK 36,995,028. The solvency ratio was 96.2%. The company had 7 employees in the financial year.
- Gross Profit
- DKK -4,433,183
- Profit/Loss
- DKK -5,904,971
- Equity
- DKK 36,995,028
- Total Assets
- DKK 38,460,805
- Employees
- 7
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -4.4 mio. | -5.9 mio. | 37 mio. | 7 |
| 2020 | - | -3.4 mio. | -5.4 mio. | 42.9 mio. | 8 |
| 2019 | - | -4.7 mio. | -6.9 mio. | 48.3 mio. | 8 |
| 2018 | - | -1.9 mio. | -4 mio. | 55.1 mio. | 6 |
| 2017 | - | -4 mio. | -4.4 mio. | 13.7 mio. | 3 |
Official annual report
Find more companies like VAR2 PHARMACEUTICALS ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
VAR2 PHARMACEUTICALS ApS has published its annual report for 2020. Gross profit came to DKK -3,413,013, and the net result was DKK -5,390,471.
About VAR2 PHARMACEUTICALS ApS
VAR2 PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ali El-Salanti and Mads Daugaard. The board consists of Mads Daugaard (chair), Ali El-Salanti, Josef Rainer and Peter Schröcksnadel. The company is owned by ONCOMAL ApS and Københavns Universitet. The company has 10 employees (2026). In 2025, the company reported a gross profit of DKK -21,739,014 and a net result of DKK -19,726,508 compared with DKK -21,006,013 the year before. Equity in the 2025 report amounted to DKK 82,032,248.